Thomas Richard Kassberg, CBO & EVP at Ultragenyx Pharmaceutical, holds 252.82K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 0.00 shares in InterMune (Ticker: ITMN). Most recently, Thomas Richard Kassberg Sold ― shares of Ultragenyx Pharmaceutical on Mar 12, 2024 for an estimated value of 574.64K.